TY - JOUR
T1 - Self-reported physical activity levels and clinical progression in early Parkinson's disease
AU - the Parkinson's Progression Markers Initiative
AU - Amara, Amy W.
AU - Chahine, Lana
AU - Seedorff, Nicholas
AU - Caspell-Garcia, Chelsea J.
AU - Coffey, Christopher
AU - Simuni, Tanya
N1 - Funding Information:
This work is funded by the Michael J. Fox Foundation for Parkinson's Research . The MJFF designed PPMI and is overseeing its conduct at the study sites, but is not involved in data analysis.
Funding Information:
PPMI—a public-private partnership—is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbvie , Avid Radiopharmaceuticals , Biogen , BioLegend , Bristol-Myers Squibb , GE Healthcare , Genentech , GlaxoSmithKline , Lilly , Lundbeck , Merck , Meso Scale Discovery , Pfizer , Piramal , Roche , Sanofi Genzyme , Servier , Takeda , Teva , UCB , and Golub Capital .
PY - 2019/4
Y1 - 2019/4
N2 - Introduction: This study investigates longitudinal changes in self-reported physical activity, measured by Physical Activity Scale of the Elderly (PASE), in early Parkinson's disease (PD) and matched healthy control (HC) participants in the Parkinson's Progression Marker Initiative (PPMI) and evaluates associations between physical activity and PD progression. Methods: PPMI is a prospective, longitudinal study evaluating markers of progression in PD participants who are unmedicated at enrollment. PASE, a self-reported measure of physical activity, was administered to early PD (N = 380) and HC (N = 174). PASE was introduced after study launch and therefore administered at years 2, 3, and 4. PASE scores for PD and HC were compared with t-tests and changes over time were evaluated with generalized estimating equations. Results: There were no differences in activity levels between PD and HC at any time point. However, PD participants had a longitudinal decrease in PASE from years two to four (p = 0.034), while HC did not (p = 0.89). In exploratory analyses controlling for age, sex, and disease duration, higher self-reported activity at year 2 were associated with slower progression of motor symptoms (p = 0.018), ADL performance (p < 0.0001), depression (p = 0.001), anxiety (p = 0.002), and cognitive decline (p = 0.016) over two years. These findings remained significant after adjusting for disease severity. Conclusion: There are no differences in self-reported physical activity between HC and early PD, but activity levels decline longitudinally in PD. Exploratory analyses show that higher self-reported physical activity is associated with less disease progression. Therefore, interventions to increase physical activity in early PD could potentially modify the disease course.
AB - Introduction: This study investigates longitudinal changes in self-reported physical activity, measured by Physical Activity Scale of the Elderly (PASE), in early Parkinson's disease (PD) and matched healthy control (HC) participants in the Parkinson's Progression Marker Initiative (PPMI) and evaluates associations between physical activity and PD progression. Methods: PPMI is a prospective, longitudinal study evaluating markers of progression in PD participants who are unmedicated at enrollment. PASE, a self-reported measure of physical activity, was administered to early PD (N = 380) and HC (N = 174). PASE was introduced after study launch and therefore administered at years 2, 3, and 4. PASE scores for PD and HC were compared with t-tests and changes over time were evaluated with generalized estimating equations. Results: There were no differences in activity levels between PD and HC at any time point. However, PD participants had a longitudinal decrease in PASE from years two to four (p = 0.034), while HC did not (p = 0.89). In exploratory analyses controlling for age, sex, and disease duration, higher self-reported activity at year 2 were associated with slower progression of motor symptoms (p = 0.018), ADL performance (p < 0.0001), depression (p = 0.001), anxiety (p = 0.002), and cognitive decline (p = 0.016) over two years. These findings remained significant after adjusting for disease severity. Conclusion: There are no differences in self-reported physical activity between HC and early PD, but activity levels decline longitudinally in PD. Exploratory analyses show that higher self-reported physical activity is associated with less disease progression. Therefore, interventions to increase physical activity in early PD could potentially modify the disease course.
KW - Disease progression
KW - Disease progression
KW - Exercise
KW - Exercise
KW - Non-motor symptoms
KW - Non-motor symptoms
KW - Parkinson's disease
KW - Parkinson's disease
KW - Physical activity
KW - Physical activity
UR - http://www.scopus.com/inward/record.url?scp=85058410866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058410866&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2018.11.006
DO - 10.1016/j.parkreldis.2018.11.006
M3 - Article
C2 - 30554993
AN - SCOPUS:85058410866
VL - 61
SP - 118
EP - 125
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
SN - 1353-8020
ER -